Loading the section
The price of Twist Bioscience Corporation (TWST) on October 9, 2026 is 159.78 USD, +5.08% on the day. Over 52 weeks the stock traded between 23.30 USD and 219.71 USD; the price now sits 69% of the way up that range. Over the past year the price changed by +387.28%. Market capitalization is 9.29 billion USD, rank 13 among 128 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Twist Bioscience Corporation trades on Nasdaq under the ticker TWST. The company belongs to the Health care sector. The trading history on this page starts on 31 October 2018.
Over the past 52 weeks TWST has traded between 23.30 $ and 219.71 $. As of 09 October 2026 the price stood 69.49 % of the way from the 52-week low to the high.
Over one year TWST shares rose 387.28 %; over six months they rose 233.50 %. Volatility over 90 days is 90.61 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 22.7, above the sector median of 3.9. Price to book is 20.4, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 152.69 | 168.93 | 152.14 | 159.78 | 4M |
| 08 October 2026 | 148.00 | 152.59 | 144.60 | 152.05 | 4M |
| 07 October 2026 | 158.26 | 167.44 | 152.50 | 155.65 | 6M |
| 06 October 2026 | 209.55 | 219.71 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Twist Bioscience Corporation (TWST) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-09-30, revenue was 376.6m $, net income was -77.7m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080, US
Twist Bioscience Corporation reported revenue of 409M $ and a net loss of 81M $ over the last four quarters. Net margin is −19.85 %. Revenue changed by +17.77 % year over year. Earnings per share are −1.32 $. Market capitalisation is 9.3B $.
TWST has a return on equity of −17.86 %, above the sector median of −41.68 %. Return on assets is −12.02 %, above the sector median of −32.11 %. Operating margin is −33.90 %, below the sector median of −26.84 %.
| 409M |
| HALOHalozyme Therapeutics, Inc. | 111.70 | +1.69 % | 251M |
| BIIBBiogen Inc. | 226.01 | +3.47 % | 224M |
| TECHBio-Techne Corp | 72.46 | +0.01 % | 215M |
| KODKodiak Sciences Inc | 99.25 | +5.29 % | 214M |
| 164.49 |
| 166.97 |
| 9M |
| 05 October 2026 | 193.46 | 207.90 | 189.25 | 205.00 | 3M |
| 02 October 2026 | 188.76 | 198.10 | 183.39 | 188.67 | 2M |
| 01 October 2026 | 193.10 | 200.31 | 187.60 | 188.05 | 3M |
| 30 September 2026 | 188.75 | 197.19 | 187.05 | 193.24 | 3M |
| 29 September 2026 | 179.90 | 190.76 | 179.73 | 186.13 | 4M |
| 28 September 2026 | 181.82 | 187.87 | 175.02 | 179.60 | 2M |
| 25 September 2026 | 184.03 | 186.20 | 177.39 | 182.83 | 3M |
| 24 September 2026 | 157.72 | 185.22 | 156.83 | 184.03 | 4M |
| 23 September 2026 | 164.35 | 166.35 | 157.41 | 158.50 | 2M |
| 22 September 2026 | 165.83 | 170.66 | 162.86 | 164.60 | 2M |
| 21 September 2026 | 168.40 | 170.23 | 160.62 | 165.83 | 2M |
| 18 September 2026 | 158.04 | 167.05 | 156.16 | 166.99 | 3M |
| 17 September 2026 | 151.43 | 163.70 | 150.00 | 155.56 | 3M |
| 16 September 2026 | 142.28 | 148.50 | 137.08 | 143.07 | 2M |
| 15 September 2026 | 134.04 | 138.93 | 131.54 | 138.10 | 1M |
| 14 September 2026 | 126.04 | 136.86 | 121.92 | 134.75 | 2M |